Results Highlights
Highlights: FY16 1Q Results (As of August 2, 2016)
-
Net sales: Declined, owing to
-
Impact of optimizing our production configuration associated with restructuring initiatives in the resin business, in addition to the stronger yen, although sales were generally steady across all businesses on the whole
-
-
Operating income and ordinary income: Declined owing to
-
Impacts of foreign exchange movements and downward revisions to NHI drug reimbursement prices, despite efforts to steadily expand the operating margin by driving growth in existing businesses and executing restructuring initiatives
- Deterioration of non-operating income and losses, mainly due to foreign exchange losses
-
-
Profit attributable to owners of parent: Largely unchanged, due to
-
Impact of tax effect accounting, etc.
-
* Profit attributable to owners of parent
